iGenomeDx Gets Award for 2022 Minority-Owned Small Business of the Year

iGenomeDx

 

iGenomeDx, a San Antonio Based Company Offering a Revolutionary DNA-Based Pharmacogenomic Test, Gets Award for 2022 Minority-Owned Small Business of the Year

iGenomeDx, a Molecular Diagnostic Laboratory, was honored to be named the 2022 Minority-Owned Small Business of the Year by the local Small Business Administration. The award was presented at a special awards ceremony held on Thursday, May 5, 2022. SBA NEWS RELEASE

 

iGenomeDx

 

DNA-Based Pharmacogenomic Test

 

Started by two individuals from India (Dr. Niti Vanee, Co-founder & CEO and Dr. Pramod Mishra, Co-founder & COO) who had a dream of making a difference in the healthcare industry, iGenomeDx is doing just that by serving the community using their scientific training and expertise. The concept behind launching iGenomeDx was to offer a DNA-based pharmacogenomic test to determine the right medication based on an individual’s genetic makeup. In other words, their DNA-based pharmacogenomic test will personalize an individual medicine thereby avoiding trial and error, reducing hospitalization due to adverse drug reactions, and decreasing healthcare costs.

 

Brings Molecular Diagnostics to San Antonio Physicians

 

iGenomeDx

 

“In 2016, iGenomeDx Inc. was founded to bring molecular diagnostics services to the physicians in the San Antonio and south Texas area. Using cutting edge technology and state of the art techniques, our team was passionate about providing accurate, fast and actionable genetic results to help make precision Medicine a reality for patients and providers in the Alamo Region,” states Dr. Niti Vanee, one of the founders and directors of iGenomeDx.

 

COVID 19 Testing Laboratory

 

During the Covid-19 Pandemic, iGenomeDx was at the testing forefront and was able to show its strength to fight this healthcare emergency alongside the doctors, nurses, and other essential workers. iGenomeDx was the 2nd laboratory in the private sector in the state of Texas to listed on FDA website as Covid-19 testing laboratory in March 2020.

 

iGenomeDx

 

 

As Dr. Pramod Mishra, Co-founder & COO iGenomeDx says, “This was our moment to step up and do our best to support the world in whatever capacity we could which is what the whole team did. We were not really thinking about the outcomes of the hard work we were all putting in at that time, but it feels humbling to see what goes in comes back in such a large way”.

 

 

“We are absolutely thrilled and honored to receive this award from our very own mentors – the U.S. Small Business Administration. It’s a major milestone for both the business as well as us, the founders,” says Dr. Vanee.

 

For more information: 

Dr. Niti Vanee, Co-founder
iGenomeDx

 

Location:

2040 Babcock Rd 201 San Antonio TX 78229

Email:

info@iGenomeDx.com

Socials:

Facebook , Twitter, Linkedin

%d bloggers like this: